MYO Logo

Myomo, Inc. (MYO) Insider Trading Activity

NYSE$3.25
Market Cap
$116.93M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
198 of 877
Rank in Industry
24 of 109

MYO Insider Trading Activity

MYO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$379,500
3
38
Sells
$576,745
5
62

Related Transactions

KIRK THOMAS Fdirector
3
$379,500
0
$0
$379,500
Mitchell MicahChief Commercial Officer
0
$0
1
$247,565
$-247,565
Kovelman HarryChief Medical Officer
0
$0
4
$329,180
$-329,180

About Myomo, Inc.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Insider Activity of Myomo, Inc.

Over the last 12 months, insiders at Myomo, Inc. have bought $379,500 and sold $576,745 worth of Myomo, Inc. stock.

On average, over the past 5 years, insiders at Myomo, Inc. have bought $262,475 and sold $204,115 worth of stock each year.

Highest buying activity among insiders over the last 12 months: KIRK THOMAS F (director) — $379,500.

The last purchase of 50,000 shares for transaction amount of $167,500 was made by KIRK THOMAS F (director) on 2025‑05‑12.

List of Insider Buy and Sell Transactions, Myomo, Inc.

2025-05-12PurchaseKIRK THOMAS Fdirector
50,000
0.1402%
$3.35
$167,500
-1.20%
2025-03-14SaleMitchell MicahChief Commercial Officer
48,000
0.1387%
$5.16
$247,565
-9.44%
2025-03-13PurchaseKIRK THOMAS Fdirector
7,400
0.022%
$5.00
$37,000
-7.30%
2025-03-12SaleKovelman HarryChief Medical Officer
30,000
0.0914%
$5.50
$165,018
-13.08%
2024-09-05SaleKovelman HarryChief Medical Officer
6,700
0.0221%
$3.76
$25,183
+29.18%
2024-09-03SaleKovelman HarryChief Medical Officer
2,029
0.0069%
$4.01
$8,140
+24.81%
2024-05-29PurchaseKIRK THOMAS Fdirector
50,000
0.174%
$3.50
$175,000
+33.38%
2024-05-15SaleKovelman HarryChief Medical Officer
35,426
0.1201%
$3.69
$130,839
+21.43%
2024-03-14PurchaseKIRK THOMAS Fdirector
50,000
0.1683%
$3.50
$175,000
+15.26%
2023-12-08SaleCrowley Thomas Aloysius Jr.director
14,997
0.0571%
$4.08
$61,188
-4.27%
2023-12-01SaleKovelman HarryChief Medical Officer
8,333
0.0296%
$3.12
$26,016
+14.41%
2023-11-28SaleCrowley Thomas Aloysius Jr.director
14,997
0.0574%
$3.27
$49,040
+19.12%
2023-11-20PurchaseKIRK THOMAS Fdirector
50,000
0.1929%
$3.10
$155,000
+23.37%
2023-09-08PurchaseMorris Milton Mayodirector
15,000
0.0565%
$1.06
$15,867
+227.36%
2023-08-30PurchaseGUDONIS PAUL RChief Executive Officer
48,400
0.2365%
$0.74
$36,039
+364.86%
2023-08-29PurchaseGUDONIS PAUL RChief Executive Officer
37,000
0.1804%
$0.78
$28,797
+335.91%
2023-08-29PurchaseHENRY DAVID AChief Financial Officer
41,666
0.1566%
$0.60
$25,000
+335.91%
2023-08-29PurchaseKovelman HarryChief Medical Officer
8,333
0.0313%
$0.60
$5,000
+335.91%
2023-08-28PurchaseGUDONIS PAUL RChief Executive Officer
42,500
0.1883%
$0.75
$31,794
+328.13%
2023-01-17PurchaseGUDONIS PAUL RChief Executive Officer
307,692
0.9391%
$0.33
$100,000
+66.14%
Total: 42
*Gray background shows transactions not older than one year

Insider Historical Profitability

71.63%
KIRK THOMAS Fdirector
305933
0.8503%
$994,282.2570
<0.0001%
Mitchell MicahChief Commercial Officer
140269
0.3899%
$455,874.2513
+66.14%
Kovelman HarryChief Medical Officer
97973
0.2723%
$318,412.2515
+335.91%
GUDONIS PAUL RChief Executive Officer
878245
2.441%
$2.85M90
+92.18%
HENRY DAVID AChief Financial Officer
352193
0.9789%
$1.14M50
+62.8%
SANGHI STEVEdirector
298513
0.8297%
$970,167.2510
<0.0001%
Morris Milton Mayodirector
77933
0.2166%
$253,282.2510
+227.36%
Naft JonathanVP, GENERAL MANAGER
74114
0.206%
$240,870.5010
<0.0001%
Crowley Thomas Aloysius Jr.director
29994
0.0834%
$97,480.5008
*Gray background shows insiders who have made transactions during last year

MYO Institutional Investors: Active Positions

Increased Positions46+97.87%5M+41.48%
Decreased Positions18-38.3%742,598-5.9%
New Positions25New3MNew
Sold Out Positions3Sold Out58,600Sold Out
Total Postitions75+59.57%17M+35.59%

MYO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Aigh Capital Management Llc$16,502.009.39%3.38M+602,719+21.69%2024-12-31
Rosalind Advisors, Inc.$14,635.008.33%3M-22,446-0.74%2024-12-31
Herr Investment Group Llc$13,889.007.91%2.85M+1M+72.93%2024-06-30
Vanguard Group Inc$6,157.003.51%1.26M+18,756+1.51%2024-12-31
Soleus Capital Management, L.P.$4,392.002.5%900,000+900,000New2024-12-31
Essex Investment Management Co Llc$3,873.002.21%793,697-105,438-11.73%2024-12-31
Clearstead Advisors, Llc$2,077.001.18%425,589+412,659+3,191.49%2024-12-31
Portolan Capital Management, Llc$1,854.001.06%379,819+379,819New2024-12-31
Susquehanna International Group, Llp$1,354.000.77%277,361+219,047+375.63%2024-12-31
Stonepine Capital Management, Llc$1,339.000.76%274,426+174,426+174.43%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.